MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with B

Bezafibrate

Bezafibrate 200mg tablets

No stability information

Stability notes for Bezafibrate 200mg tablets

There are no stability notes for this medicine.

Suppliers (4) of Bezafibrate 200mg tablets
Bezafibrate 200mg tablets (A A H Pharmaceuticals Ltd)
Bezafibrate 200mg tablets (Alliance Healthcare (Distribution) Ltd)
Bezafibrate 200mg tablets (Noumed Life Sciences Ltd)
Bezafibrate 200mg tablets (Teva UK Ltd)

Bezafibrate 400mg modified-release tablets

No stability information

Stability notes for Bezafibrate 400mg modified-release tablets

There are no stability notes for this medicine.

Suppliers (5) of Bezafibrate 400mg modified-release tablets
Bezafibrate 400mg modified-release tablets (Teva UK Ltd)
Bezalip Mono 400mg modified-release tablets (Lexon (UK) Ltd)
Bezalip Mono 400mg modified-release tablets (Necessity Supplies Ltd)
Bezalip Mono 400mg modified-release tablets (Sigma Pharmaceuticals Plc)
Lipozate 400mg modified-release tablets (Noumed Life Sciences Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.